A Narrative by AV Jayakumar, President – Corporate Quality Assurance, Ajanta PharmaIn the high-stakes world where every action of Indian pharma companies is closely watched, cross-contamination is a challenge that requires constant vigilance. As someone deeply entrenched in the industry, AV Jayakumar has first-hand experience of how easily contamination can compromise a product's integrity. During…
Blog - Page 2 of 4 - FZCO
Impurities have become a significant concern for the industry, particularly following recent discoveries of harmful contaminants in widely used drugs. The presence of Diethylene Glycol (DEG) and Ethylene Glycol (EG) in medicinal products has emerged as a critical issue, leading to global recalls and triggering more stringent regulations by agencies like the U.S. FDA. These…
In an era where the complexity of medicines continues to grow, the need for robust pharmacovigilance has never been more critical. Beyond safeguarding patient health, effective drug monitoring systems are pivotal in reducing healthcare costs and sustaining economic stability. To delve deeper into the economic impact of pharmacovigilance, our Head of Research and Production, Ms.…
Jegan IsraelGeneral Manager Quality & ComplianceZydus LifesciencesEvery life science company knows that quality is of the utmost importance. But defining quality and aligning that definition to regulations requires an intentional approach and this is how QMS came into the picture. QMS; Quality Management System, a comprehensive system that a an organization uses to manage quality…
Subhrangshu ChaudhuryVice President & Head of Quality Centaur PharmaceuticalsOver the past few years, the term “Quality Culture” has become quite a buzzword. I recently attended a conference where senior leaders across different industries were discussing this topic. It triggered my thoughts. I am a quality leader who has worked in pharma for almost two decades…
Two decades ago, the Indian pharmaceutical industry faced a seismic shift as data integrity issues emerged, challenging the core operations of the sector. Today, pharma professionals operate in a transformed landscape where stringent data integrity controls are the norm, ensuring compliance and maintaining quality standards.The current pharmaceutical environment places quality above all else, with rigorous…
20 Things Never to Say to an FDA Investigator Inspired by Vincent F Cafiso the Director of Quality and Regulatory Services at CREO and a former FDA Investigator – presented by Vrushali Negandhi I always look forward to the little anecdotes that Vincent Cafiso shares from time to time. Vincent, the Director of Quality and…
In the fast-paced world of pharmaceuticals, precision and compliance are paramount. As technological advancements reshape the industry, computer software assurance (CSA) and validation have become critical components in ensuring quality and regulatory compliance. With the advent of artificial intelligence (AI) and other cutting-edge technologies, the landscape of CSA is evolving rapidly. However, these advancements are…
The pharmaceutical industry, a realm of constant innovation and regulatory stringency, has found itself at the crossroads of technology and tradition. In this dynamic landscape, Artificial Intelligence (AI) emerges as a beacon of transformative potential, particularly in quality management. As we embark on a journey through the corridors of Indian Pharma, the question that looms…
Introduction:The Pharmaceutical industry is a highly data sensitive, complex and regulated sector that requires effective and continual innovation. The integration of popular Artificial Intelligence (AI) tools from the open market is not a feasible option for Project Management in the Pharma industry. AI can play a pivotal role in the streamlining processes, enhance decision-making, and…